1-4 of 4
Dina S. Parekh
Close
Sort by
Journal Articles

Recent developments in the use of pyruvate kinase activators as a new approach for treating sickle cell disease

Dina S. Parekh, William A. Eaton, Swee Lay Thein
Journal: Blood
Blood (2024) 143 (10): 866–871.
https://doi.org/10.1182/blood.2023021167
Published: 2024
Journal Articles

Longitudinal Characterization of Hemodynamic Changes with Multimodal Optical Techniques in Patients with Sickle Cell Disease Treated with Mitapivat

Timothy Quang, Ingrid Frey, Julia Xu, Golnar Mostashari, Anna Conrey, Dina S. Parekh, Ruth Pierre Charles, Brian Hill, Swee Lay Thein, Bruce J Tromberg
Journal: Blood
Blood (2023) 142 (Supplement 1): 2492.
https://doi.org/10.1182/blood-2023-174227
Published: 2023
Journal Articles

A Retrospective Review of Mercaptopurine Metabolism Reveals High Rate of Patients with Suboptimal Metabolites Successfully Corrected with Allopurinol

Lauren Marie Vasta, MD, Richard C Zanetti, MD, Dina S. Parekh, MD, Anne B. Warwick, MD MPH, Kenneth Lieuw, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3878.
https://doi.org/10.1182/blood-2019-126184
Published: 2019
Journal Articles

Novel V1551L Mutation in SAMD9L Inhibits Cell Cycle Progression and Results in Pancytopenia That Progresses to MDS with Monosomy 7

Rebecca Ortolano, MD, Dina S. Parekh, MD, Benjamin J Rosen, MD, Victoria Bryant, PhD MSc, Dong-Hui Chen, PhD, Jeffery M. Klco, MD PhD, Wendy Herlihy Raskind, MD PhD, Kenneth Lieuw, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3863.
https://doi.org/10.1182/blood-2018-99-120250
Published: 2018